• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

AstraZeneca Buys CinCor in a Deal Worth Up to $1.8B

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Jan 09, 2023 at 11:22: AM
via AstraZeneca has inked a definitive agreement to acquire cardiorenal disease player CinCor Pharma in a deal that could potentially reach $1.8 billion in total value, the companies announced Monday.

article source
 




Top Bottom
Back
Quote